- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 107.34M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $162.39M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $229.37M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $8.75M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $13.75M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $94.57M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $184.79M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $106.1M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $105.38M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $435.91M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $607.19M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $156.08M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $161.16M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $372.75M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $482.2M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $273.44M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $370.17M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $808.66M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.09B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 117.43M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $266K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $16.59M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $16.88M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $10.13M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$9.52M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$16.25M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $50.38M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $13.1M |
| Revenue | Q1 2025 · Mar 31, 2024 | $63.48M |